Objective: To evaluate the effect of treatment with murine recombinant interleukin-1 beta on inflammatory infiltrate and tissue damage after experimental endotoxic challenge.
Design: Randomized, controlled study.
Setting: Experimental Unit, Virgen de las Nieves University Hospital.